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ABSTRACT 
 
Holoprosencephaly is a heterogeneous craniofacial and neural developmental anomaly 
characterized in its most severe form by the failure of the forebrain to divide.  In humans 
holoprosencephaly is associated with disruption of Sonic hedgehog and Nodal signaling pathways, 
but the role of other signaling pathways has not yet been determined.  In this study we analyzed 
mice which, due to the lack of the Bmp antagonist Noggin, exhibit elevated Bmp signaling.  
Noggin-/- mice exhibited a solitary median maxillary incisor that developed from a single dental 
placode, early midfacial narrowing as well as abnormalities in the developing hyoid bone, pituitary 
gland and vomeronasal organ.  In Noggin-/- mice, the expression domains of Shh, as well as the 
Shh target genes Ptch1 and Gli1, were reduced in the frontonasal region at key stages of early 
facial development.  Using E10.5 facial cultures we show that excessive BMP4 results in reduced 
Fgf8 and Ptch1 expression.  These data suggest that increased Bmp signaling in Noggin-/- mice 
results in downregulation of the hedgehog pathway at a critical stage when the midline craniofacial 
structures are developing, that leads to a phenotype consistent with a microform of 
holoprosencephaly.   
 
 
INTRODUCTION 
 
Holoprosencephaly (HPE) is a developmental anomaly that can present as a range of midline 
craniofacial and neural malformations.  HPE is the most common developmental defect of the 
forebrain and is characterized by the abnormal separation of the telencephalon into left and right 
hemispheres and the associated abnormal development of midline neural structures.  Alobar HPE 
is the most severe form of this developmental defect, in which the prosencephalon does not 
separate along both its medial-lateral and anterior-posterior axes which results in a single 
uncleaved cerebral lobe and the telencephalon and diencephalon remain unsegmented.  There is a 
spectrum of clinical facial features including the presence of only one upper central incisor tooth 
with an absent maxillary midline frenum, cleft of the lip and or palate, nasal defects including 
single nostril and nasal agenesis, central proboscis, hypotelorism (shortening of the distance 
between the eyes) and cyclopia (1, 2).  When these features appear without defects in the CNS 
they are termed “microforms”.  HPE occurs 1 in 7,600 live births (3).  However the incidence is 
much higher, 1 in 240, during early embryogenesis with most embryos undergoing spontaneous 
abortion (4).   
The etiology of HPE is heterogeneous with both genetic and environmental factors.  
Environmental factors include poorly controlled maternal diabetes, alcohol, vitamin A analogues 
 3
and alteration in cholesterol metabolism (5).  Approximately 25% of HPE cases are syndromic; 
these syndromes include Pallister-Hall, Rubinstein-Taybi and Smith-Lemli-Opitz.  In non 
syndromic cases, 12 different chromosomal loci have been implicated in HPE and mutations in 7 
genes have been found to cause HPE, and these are all members of the Hedgehog and Nodal 
signaling pathways.  Genes with known mutations causing HPE are SHH (HPE3), the Hedgehog 
receptor Patched 1 (PTCH1) (HPE7), the transcription factors GLI2, SIX3 (HPE2) and ZIC2 
(HPE5) as well as Transforming growth factor interacting factor (TGIF) and Teratocarcinoma-
derived growth factor 1 (TDGF1/CRIPTO) (6, 7).  
Evidence from animal forebrain developmental studies and the characterization of some of 
the genes causing HPE in humans suggests that distinct mechanisms underlie the two major 
classes of HPE (8).  Firstly, ‘classic’ HPE, in which the ventral telencephalon is most severely 
affected and where the ventralizing effects of Shh signaling are disrupted.  Secondly, midline 
interhemispheric HPE or syntelencephaly in which the dorsal telencephalon fails to split while the 
ventral telencephalon may be normal, and the dorsalizing effect of Bone morphogenetic protein 
(Bmp) signaling is disrupted.  Evidence for the role of Bmp signaling in the pathogenesis of 
midline interhemispheric HPE comes from the analysis of Bmpr1a-/-;Bmpr1b-/- compound mutant 
mice which exhibit a loss of all dorsal midline cell types without affecting the specification of 
cortical and ventral precursors in the telencephalon (9).   
Bmps regulate many aspects of craniofacial morphogenesis (10).  Variations in Bmp 
signaling create morphological species-specific diversification of the middle and upper face (11, 
12) and Bmps together with retinoid acid specify the identity and regulate the growth of the 
frontonasal mass and maxillary prominences (13, 14).  Noggin is an extracellular Bmp antagonist 
which binds, with picomolar affinity, to Bmp2, 4, 6 and 7 (15).  This high binding affinity prevents 
Bmps from binding to their receptors and subsequent signal transduction.  Noggin null allele mice 
exhibit elevated Bmp signaling which results in patterning and growth defects of the neural tube 
and somites, in the appendicular and axial skeleton cartilage is hyperplastic and there is a failure to 
initiate joint formation (16-19).   
In this study we show that Noggin is expressed in the midline of the developing upper face 
and that Noggin-/- mouse embryos exhibit craniofacial abnormalities which equate to a microform 
HPE.  More specifically, the mutant mice display a solitary median maxillary incisor, midfacial 
narrowing and abnormalities in the developing hyoid bone, pituitary gland and vomeronasal organ.  
The Shh signaling pathway regulates midface development and has also been implicated in HPE.  
We examined the expression of mRNA encoding Shh and the Shh target genes Ptch1 and Gli1 
during early facial development.  We found smaller expression domains of Shh, Ptch1 and Gli1 in 
the frontonasal region of Noggin-/- mice compared to their wild type littermates.  Using bead 
implantation assays on E10.5 Wt upper facial explants, we show that excessive BMP4 protein 
results in reduced expression of both Fgf8 and Ptch1.   
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Taken together, the present data suggests that disrupted Bmp signaling can result in HPE 
by regulating the Fgf8-Shh pathway and we put forward the Noggin-/- mouse as a model of 
microform HPE.   
 
 
RESULTS  
 
Noggin-/- mice exhibit a narrowing of the frontonasal process and a solitary median upper 
incisor 
Noggin expression, revealed by LacZ staining, was analyzed in mice at keys stages when the 
midline of the upper face is patterned and undergoing major morphogenesis. At E9.5 and E12.5 
Noggin was detected in the midline of the developing frontonasal process and in the developing nasal 
pits (Fig. 1). A hallmark of the facial features of HPE is midfacial narrowing which ultimately may 
result in hypotelorism, or a narrowing of the distance between the eyes.  E11.5 Noggin-/- mouse 
embryos exhibited a shorter distance between the lateral nasal processes compared to their wild 
type (Wt) littermates. Furthermore, the morphology of the frontonasal mass was abnormal, with 
Noggin mutant mice lacking the characteristic invagination of the anterior/oral surface (Fig. 1).  To 
quantify these changes we have carried out measurements on tissue sections from Wt and noggin 
null mice stained for Pax9 expression, a transcription factor used as a marker of the nasal 
processes.  In the absence of Noggin, the distance between the nasal pits was found to be 
significantly reduced at E11.5 (P=0.02; Wt = 1.14mm, n = 12; Noggin-/- 0.86 mm, n = 9, non 
paired t-test) (Fig. 1).  
 Wild type mice have two upper incisor teeth, each within separate premaxillary bones.  
Noggin-/- mice had a single upper incisor located in the midline in a single premaxillary bone (Fig. 
2).  The morphology of the incisor was analyzed in histological sections at E16.5 (Fig. 2C, D). 
Instead of two separated tooth germs positioned adjacently to the nasal cavity and separated by the 
inter premaxillary suture, Noggin-/- mice had a single midline incisor situated below the nasal 
septum.   
In order to establish whether this tooth had developed from a single primordium or from 
the fusion of two well defined primordia, we analyzed early tooth development in Noggin-/- mice 
and their Wt littermates.  During tooth development, Shh is expressed in dental placodes, which 
are thickenings of the oral epithelium and represent the earliest stages of tooth development.  We 
performed whole mount in situ hybridization for Shh mRNA at E11.5 and E12.5 and found that 
Noggin-/- mice exhibit a single Shh expression domain in the midline of the frontonasal process 
(9/10 mice) (Fig. 2).  This expression domain had not formed from two placodes, as occurs in Wt 
mice.  In Wt mice, two maxillary incisor primordia were seen at E12.5, these had formed from a 
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continuous dental lamina.  Also, we noted that the Shh expression domains in the incisor placodes 
were smaller in Noggin-/- mice compared to Wt littermates (Fig. 2).   
Consistent with previous reports, we found that the cranial neural tube of most Noggin-/- 
mice (18/22 E17.5 and E18.5 mice) failed to close leaving the mutants with an exencephalic 
phenotype (18).  
 
Shh signal transduction is decreased in the oral region in Noggin-/- mice 
As Shh expression domains in the incisor placode were smaller in Noggin-/- mice compared to Wt 
and because Shh signaling has been shown to developmentally regulate midfacial width, we 
compared the expression of several genes involved in the Shh pathway in the midline facial 
regions of Wt and Noggin-/- mice during early embryogenesis (E11.5 and E12.5) (Fig. 3).  In Wt 
mice, Shh was expressed in the oral epithelium and facial ectoderm, as well as the pharyngeal 
endoderm and diencephalic epithelium.  In Noggin-/- mice Shh was absent from the oral epithelium 
(Fig. 3D).  The transmembrane receptor Ptch1 and the transcription factor Gli1 are both targets of 
Shh.  Consistent with previous reports that there is a gradient of Hh signaling activity across the 
craniofacial region (20), we found that in Wt mice the expression of Ptch1 and Gli1 was strongest 
near to the expression domains of Shh and that this mesenchymal expression reduced linearly with 
increasing distance from the epithelium (Fig. 3C-J).  In Noggin-/- mice the expression levels of 
Ptch1 and Gli1 in the mesenchyme adjacent to the oral epithelium was reduced, consistent with the 
reduction of Shh expression (Figs. 3F, H, J).  
As Bmp2, -4 and -7 are binding partners of Noggin and because the Noggin null 
phenotype is caused by the deregulation of Bmp signaling (16, 21), we analyzed the expression of 
Bmp2, -4 and -7 during early facial development.  Noggin is expressed in the epithelium of the 
developing frontonasal mass (Fig. 1A-C) (22).  At E10.5 Bmp2 was expressed in the nasal 
epithelium then at E12.5 in the pharyngeal endoderm and in the mandibular process.  Bmp4 and 
Bmp7 were expressed in the facial, oral and mandibular epithelia as well as in the mesenchyme of 
the frontonasal mass and the first branchial arch (mandible) at both E10.5 and E12.5 
(Supplemental Fig. 1).  
It has been reported that Bmp4 expression is more intense and has an expanded domain in 
the first branchial arch of Noggin-/- mice compared to Wt littermates (23).  Using in situ 
hybridization, we tested whether the expression of Bmp4 and Bmp7 were changed in the midline of 
the developing face in Noggin-/- mice.  Similar to Wt littermates, Bmp4 and Bmp7 were expressed 
in the epithelium and mesenchyme of the frontonasal mass and in the first branchial arch.  Levels 
of intensity were comparable to those found in Wt littermates (Supplemental Fig. 1).   
 
BMP4 inhibits Fgf8 and Ptch1 in the developing midface 
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In the developing chick face, it has been shown that increasing levels of Bmp leads to a 
downregulation of Fgf8 and Shh (22). We postulated that increased Bmp signaling could, via Fgf8, 
reduce Shh signaling in the developing frontonasal process and thereby result in the Noggin-/- 
phenotype. Using bead assays we tested the effects of adding exogenous BMP4 to E10.5 mouse 
facial organ cultures.  BMP4 downregulated Fgf8 in the nasal pit (8/9 explants, compared to 2/9 
with BSA) (Fig. 4). Fgf8 and Shh are expressed in the facial ectoderm, however, Shh signals to its 
receptor Ptch1 which is located in the facial mesenchyme to regulate facial morphogenesis.  As 
ligand binding to Ptch1 initiates signal transduction and as Ptch1 is also upregulated by the 
binding of Hh, Ptch1 expression is regarded as a readout of Hh signaling. We therefore 
investigated the effects of BMP4 on Ptch1 expression in the developing mouse frontonasal process 
and found that BMP4 downregulated Ptch1 expression (9/11 explants, compared to 2/11 with 
BSA).  Thus, in Noggin null allele mice increased Bmp activity may inhibit Fgf 8/Shh-dependent 
facial development.  
 
Normal palate formation despite abnormal early shelf morphogenesis 
Cleft lip and/or palate are part of the spectrum of features in human HPE.  We examined the 
developing lips and palate of Noggin-/- and wild type mice from the initial stages of development at 
E12.5 until after palatal shelf fusion is complete at E16.5 and E18.5.  Normally, the palatal shelves 
develop as buds from maxillary processes and then start to grow downwards between the tongue 
and the floor of the mouth.  The palatal shelves elevate rapidly between E14.0 and E14.5 to a 
position above the tongue, where after they approximate in the midline and fuse.  In Noggin-/- mice 
the palatal shelves appeared morphologically normal at E12.5, however at E13.5 they were thick 
and bulbous in shape and had failed to grow down between the tongue and floor of mouth instead 
remaining above the dorsum of the tongue (Fig. 5).  Noggin-/- palatal shelves met in the midline 
and fused normally so that by E16.5 a normal palate had formed (20/21 mice) (Fig. 5G and H).   
 It seems likely that this phenotype is, at least in part, secondary to abnormalities causing 
the mandible and tongue to be held down so that the palatal shelves remain above the tongue.  
Meckel’s cartilages in Noggin-/- mice were greatly enlarged holding the oral cavity open (Fig. 5).  
In addition, there were developmental abnormalities in the hyoid bone.  The hyoid bone is a U-
shaped bone positioned below the mandible in the anterior triangle of the neck.  It gives 
attachment to muscles controlling the function of the tongue and mandible.  The hyoid comprises a 
body, two greater cornua and two lesser cornua.  It develops from cartilages from the pharyngeal 
arches (PA), the body from both PA II and III, the lesser cornua from PA II and the greater cornua 
from PA III.  We examined the hyoid bones by alizarin red (bone) and alcian blue (cartilage) 
staining at E16.5, E17.5 and E18.5.  Already at E16.5 the mutant hyoid bones/cartilages were 
much larger than in their Wt littermates (Fig. 5I and J).  In Wt E18.5 mice the hyoid was 
composed of a body and greater cornua with the lesser cornua developing later, while the hyoid of 
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Noggin-/- mice was abnormal in size, shape and number of cornua (Fig. 5K and L) (5/5 mice).  The 
body of the hyoid bone was enlarged greatly and its shape changed with four instead of two 
cornua.  These cornua were shorter, wider and mineralized distally compared to the cornua of Wt 
littermates.   
In Wt mice the palatal shelves develop in an oral cavity that is expanding in all directions.  
As Noggin-/- mice exhibit a lack of midfacial transverse growth the oral cavity is narrow and this 
may allow the palatal shelves to touch and fuse so that a ‘normal’ palate could form.  That said, 2 
out of 31 Noggin-/- mice exhibited facial clefts and 1 out of 21 mice exhibited a cleft palate (data 
not shown).   
 
The vomeronasal capsule is absent in Noggin-/- mice 
The vomeronasal organ (VO) (also known as Jacobson’s organ) is an auxiliary olfactory sense 
organ situated adjacent to the cartilage of the nasal septum, mainly used to detect pheromones.  
The VO is a c-shaped structure surrounded by a cartilaginous capsule which opens into the base of 
the nasal cavity.  The vomeronasal capsule is a structure distinct from the nasal septum, which it 
neighbors.  Histological analysis of frontal section of Noggin-/- E16.5 heads revealed that the 
epithelial section of the VO appeared normal (Fig. 6).  However, the vomeronasal capsule was 
missing in the Noggin-/- mutants and the mesenchyme around the VO was reduced in size (in all 
animals examined).   
 
Pituitary gland abnormalities in Noggin-/- mice 
The developing pituitary gland was analyzed in sagittal and coronal sections at E13.5, E14.5 and 
E16.5 (Supplemental Fig. 2, data not shown).  The most notable feature in Noggin-/- mice was that 
the developing pituitary was smaller when compared to Wt mice, especially the pars anterior.  The 
pars anterior (pars distalis) ultimately produces the most of the pituitary hormones.  Other defects 
that have previously been reported in Noggin-/- mice include a rostral displacement of Rathke’s 
pouch and the induction of secondary pituitary tissue (24).   
 
 
DISCUSSION 
 
Noggin null allele mice exhibit several craniofacial abnormalities including a narrowed frontonasal 
process, a solitary median maxillary incisor, and defects in the hyoid bone, vomeronasal organ and 
pituitary gland.  All these Noggin-related facial anomalies are characteristic of a microform of 
holoprosencephaly and are associated with reduced expression of hedgehog target genes. Our 
findings are consistent with the hypothesis that Bmps have a role in midline patterning and the 
regulation of midface width by inhibiting Shh signaling.   
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Solitary median upper incisor  
Wild type mice have two upper incisors.  We found that Noggin-/- mice have a solitary median 
upper incisor, which develops from single expression domain in the midline of a single 
premaxillary bone.  We can not rule out that the single Shh expression domain is a consequence of 
a lack midline tissue intervening between two anlagen which have subsequently fused together.  
Although this is relatively unlikely as the centrally located Shh domain in the Noggin-/- mice is 
smaller than the individual domain of Wt upper incisors.  Alterations in the number of teeth can be 
caused by irregularities in the tooth initiation process (25).  In Noggin-/- mice, the single incisor is 
part of a HPE midfacial phenotype where the lack of tissue in the midline and a patterning defect 
are responsible for the tooth phenotype.  Overactivation of Noggin in the oral epithelium using 
transgenic tools (K14 promoter) does not result in a change in the number of incisors.  However, 
the morphology and structure of the K14-Noggin incisors is altered: incisors are large with 
abnormalities in enamel and dentine formation.  In addition, all mandibular and maxillary third 
molars are lost due to developmental arrest at the early bud stage (26).   
Humans normally have two deciduous and two permanent central incisors and the 
development of a solitary median maxillary central incisor (SMMCI) in the primary and/or 
secondary dentition is rare.  SMMCI can occur as part of a holoprosencephalic phenotype, in 
association with abnormalities not related to HPE or as an apparently isolated finding.  Missense 
mutations in SHH have been reported in patients with SMMCI that do not have other features of 
HPE (27, 28).  The I111F mutation has been  found in eight members of the same family and it has 
been suggested that this mutation may be specific for SMMCI as it has not been found in either 
HPE patients or in a normal population (27).   
Hypopituitarism due to pituitary hypoplasia has been described in patients with SMMCI 
together with other HPE-like features and has been reported in patients with loss of function 
mutations in the HH signaling transcription factor GLI2 (29, 30).  In zebrafish, it has been shown 
that Gli1 and Gli2 regulate Hh signaling to induce and pattern the developing adenohypophysis 
(31).  And in mice, 50% of Gli2-/- mutants and 100% of Gli2-/-;Gli1-/- mutants fail to develop a 
pituitary gland (32).  Whether Bmp and Hh signaling interact during pituitary development is not 
known.  In Noggin-/- mice the pituitary abnormalities appear to be due to an expanded domain of 
Bmp4 activity that results in Fgf10 repression and rostral shift of the Bmp4 and Shh boundary (24).   
 
Midfacial width is regulated by Noggin 
Several studies have analyzed the role of Bmps and other growth factors in the control of facial 
proximal/distal outgrowth but very few have addressed what controls facial width.  Here we show 
that Bmp, by modulating Shh signaling, plays a fundamental role in regulating facial width.  
Although the facial features of Noggin-/- mice have not been previously reported, there is evidence 
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that Bmps control facial patterning and growth and that alteration of Bmp signaling can lead to 
holoprosencephaly.  For instance, compound mouse mutants for Chordin and Noggin (33, 34) or 
chick embryos that have had BMP4-soaked beads implanted into their forebrains (35) exhibit 
holoprosencephalic facial features including cyclopia, a central proboscis and orofacial clefting.  
With regard to the proximal/distal outgrowth of the facial processes, Noggin-soaked beads 
implanted into the developing chick face at different developmental stages results in decreased cell 
proliferation and subsequently decreased outgrowth, smaller frontonasal and maxillary processes 
and deletion of the maxillary and palatine bones (13, 14, 22).   
We show that in Noggin-/- mice Shh and the Shh target genes Ptch1 and Gli1 are 
misexpressed at E11.5 and E12.5 in the developing face.  This suggests that disrupted Bmp 
signaling in Noggin-/- mice results in downregulation of the hedgehog pathway at the critical time 
when the midline craniofacial structures are developing.  This is supported by experiments in the 
developing chick, that demonstrate that excessive exogenous BMP2 (micro bead implantation) 
downregulates Shh expression (22), and transient loss of SHH signaling by either excision of the 
frontonasal epithelium or by the introduction of Shh neutralizing antibodies inhibits growth of the 
facial primordia and results in a narrowing of the mid and upper face  and subsequent 
hypotelorism, decreased distance between the eyes, which is a characteristic of mild 
holoprosencephaly (36).  Also, mice lacking the transmembrane protein Cdo, which positively 
regulates Shh signaling, exhibit holoprosencephaly with a midface hypoplasia and hypotelorism 
(37).   
Disruption in Shh signal transduction by exposing chick embryos, at Hamilton Hamburger 
stages 15 and 17, to the Smoothened inhibitor cyclopamine, results in a continuum of HPE-related 
defects including hypotelorism (38).  The time when Shh signaling, and presumably Bmp 
signaling, is blocked is critical.  Early blockade of Shh (before the division of the eye field into 
two) (stage 4) causes cyclopia, Shh blockage later (stages 15 and 17) results in decreased distance 
between the eyes (hypotelorism), midfacial hypoplasia and orofacial clefting, while blockage later 
in development has no effect (38).  Conversely, excessive SHH in the embryonic face leads to 
increased proliferation in the frontonasal process, increased width of mid and upper facial 
processes and consequently hypertelorism (36).  When considering facial development, it is 
important to differentiate between early abnormal Shh signaling from the developing brain and 
signaling later from the developing facial structures.   
In this study, we show that in exogenous BMP4 inhibits Fgf8 and hedgehog receptor 
Ptch1 in the developing mouse frontonasal process.  Fgf8 is a key regulator of facial development 
which is known to regulate Shh signaling in several embryonic locations including the limb and 
genital tubercle.  Blocking Fgf signaling in the developing chick face results in a narrowing of the 
upper face, approximation of the maxillary processes and a coalescence of the nasal pits into a 
single central pit (39).  There is good evidence that during very early chick facial development 
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Bmp signaling acts to restrict Fgf8 expression (40).  Equally, blocking endogenous Bmp signaling 
in the developing chick frontonasal prominence, by overexpressing Noggin results in an expansion 
of the Fgf8 domain (39).  Taken together, the downregulation of Fgf8 and Hedgehog signaling by 
excessive Bmp signaling provides a mechanism underlying the HPE in the Noggin null allele 
mouse.  
Mutations in SHH/Shh, as well as mutations in several hedgehog signaling pathway 
members, result in HPE in both humans and mice.  Human and mouse mutations of GLI2/Gli2 
have been shown to cause HPE-like phenotypes including midfacial hypoplasia with a single 
maxillary incisor (30, 41).  A SHH missense mutation has been associated with HPE and to cause 
defective binding to the HH regulator GAS1 (42).  Similar to Noggin-/- mutants, 40-50% of Gas1-/- 
mice exhibit several features consistent with a microform of HPE including a single maxillary 
incisor, a narrow frontonasal process and abnormalities in the pituitary, palate and vomeronasal 
organ (20).  The Gas1-/- phenotype appears to be due to a reduction in Shh signaling as loss of a 
single allele of Shh in the Gas1-/- background worsened the craniofacial phenotype and Gas1-/- 
mice exhibit a reduced Ptch1 expression domain in the developing frontonasal process (20, 43).  
Noggin-/- mice have a narrow facial width and malformed neural crest cell derivatives, 
namely the upper incisors, premaxillary bones, nasal septum and the palate.  There is evidence that 
Bmp signaling is important in neural crest induction, delamination and migration and it has been 
suggested that elevated Bmp signaling disrupts the development of postmigratory, differentiating 
skeletal neural crest cells (17, 23, 33).  Thus overexpression of Noggin in the second branchial 
arch (Hoxa2) results in reduced numbers of neural crest cells and consequently hypomorphic 
skeletal and neural elements (44).  Also, Noggin may protect neural crest cells from apoptosis 
induced directly by elevated Bmp signaling, and indirectly by maintaining Shh signaling as 
Noggin and also Chordin promote the rostral expression of Shh  (33).  Noggin and Chordin are 
Bmp antagonists that have similar biochemical activity and expression domains and may well 
compensate functionally for each other.  Compound mutant mice for Noggin and Chordin display 
a variety of HPE craniofacial defects (23, 33, 34).  Consistent with our data, disruption of Bmp 
and Follistatin signaling in the chick results in a holoprosencephalic phenotype through a 
mechanism which involves modulating midline Shh signaling (45).   
Despite multiple regulators controlling the Bmp pathway, disruption of Noggin alone is 
sufficient to result in the mid facial phenotype described in this paper.  In conclusion, we 
demonstrate the importance of Noggin in the correct patterning of the face and in the etiology of 
holoprosencephaly.   
 
 
MATERIALS AND METHODS 
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Mice 
The generation, breeding and genotyping of the Noggin mutant mice used in this study have been 
described previously (16, 21).  The initial inactivation of the Noggin gene was done in an inbred 
129SvJ genetic background.  Heterozygote males have been serially backcrossed with CD1 
females for at least ten generations.  NogginLacZ reporter mice were backcrossed to C57BL/6 and 
used as heterozygotes.  
 
Skeletal and LacZ staining 
Alcian blue/alizarin red and LacZ staining were performed according to Rice et al 2010 and 
Zouvelou et al 2009 (46, 47).  
 
Organ culture 
E10.5 and E11.5 Wt mouse heads were dissected and placed on Nuclepore filters in a Trowell-type 
organ culture system as described previously (48).  Affi-gel agarose beads (Biorad) were incubated 
with recombinant human BMP4 (100 ng/!l, R&D Systems) or BSA at 37°C for 1 hour and stored 
at 4°C before being placed on the explants. Bead assays were cultured overnight.  
 
Preparation of probes and in situ hybridization 
35S in situ hybridization on paraffin sections was performed as previously described (49).  Both 
bright and dark field images were taken of hybridized sections.  Silver grains were selected from 
the dark field images, colored red and then superimposed onto the identical bright field image 
using Adobe Photoshop 6.0 software.  Whole mount in situ hybridization was performed using 
digoxigenin-UTP-labelled riboprobes as previously described (50).  The preparation of the Bmp, 
Fgf8, Gli1, Pax9, Ptch1 and Shh RNA probes has been described previously (51-53).   
 
Statistical analysis 
An independent samples t-test was used for the statistical analysis of normally distributed samples.  
A *, P value of less than 0.05 was considered statistically significant. SPSS 15.0 was used for the 
statistical analysis of the data. 
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LEGENDS TO FIGURES 
 
Figure 1. Noggin is expressed in the developing face and Noggin-/- mice exhibit a narrow 
frontonasal process.  (A, B) Whole mount LacZ staining of E9.5 and E12.5 mice. At E9.5 Noggin is 
expressed in the midline of the developing frontonasal process (arrowhead). Later Noggin expression is 
detected in the midline of the frontonasal process as fine line which extends into the oral cavity (arrow) 
and in the developing nasal pits (asterisks).  (D, E) Schematic diagram illustrates the upper face of 
an E11.5 mouse embryo.  The red arrow indicates the distance between the nasal pits.  Noggin-/- 
mice have a shorter distance between the nasal pits. (F, G) Localization of Pax9 in the developing 
upper face of E11.5 Wt and Noggin-/- mice.  Using Pax9 as a marker of the lateral and medial nasal 
processes we were able to record a reduction in the distance between the nasal pits in Noggin-/- 
heads compared to their Wt littermates. fnp, frontonasal process; lnp, lateral nasal process; mnp, 
medial nasal process; np, nasal pit. Scale bar: 1 mm. (F and G, same magnification). Error bars: 
standard deviation.  
 
Figure 2. Noggin-/- mice has a solitary median upper incisor tooth. (A, B) Premaxillary region of 
new born Wt and Noggin-/- mice stained with alcian blue (cartilage) and alizarin red (bone). Wt 
mice have two upper incisor teeth (A arrowheads) whereas Noggin-/- mice have only one (B 
arrowhead).  (C, D) Hematoxylin and eosin stained frontal sections from E16.5 Wt and Noggin-/- 
heads confirming the presence of two upper incisors in Wt mice and a single upper incisor in 
Noggin-/- mice (arrowheads).  The developing upper incisor in Noggin-/- mice has an abnormal 
thick stalk attachment to the oral epithelium and abnormal epithelial convolutions (D).  Associated 
with the dental epithelium is a condensed dental mesenchyme.  (E-H) Shh whole mount in situ 
hybridization of E11.5 and E12.5 Wt and Noggin-/- oral region. (E) In Wt mice, at E11.5, Shh 
expression is seen in the two mandibular incisors (arrowheads) and in the continuous maxillary 
dental lamina (arrow).  (F) In Noggin-/- mice dental development is delayed in that Shh mRNA is 
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not detected in the oral region. (G, H) At E12.5 Wt mice have two upper incisor primordia (G 
arrowheads) and two lower incisor primordia which express Shh.  Noggin-/- exhibit two lower 
primordia which express Shh but have only one centrally positioned incisor primordium which is 
smaller than its Wt counterparts (F arrowhead).  np nasal pit; ns, nasal septum; t, tongue. Scale 
bars: 0.5 mm. Images on the left of the panel are the same magnification as the images on the 
right.   
 
Figure 3.  Decreased Shh signal transduction in the oral region of Noggin-/- mice.  (A-H) Sagittal 
sections through the midline region of Wt and Noggin-/- mice. (A-H) E11.5 (A, B) Hematoxylin 
and eosin stained sections.  (C-J) 35S-in situ hybridization for Shh signaling pathway members.  
(C, D) Shh is expressed in the oral epithelium (C arrowhead), pharyngeal endoderm and neuro 
epithelium of the diencephalon.  In Noggin-/- mutant mice the expression of Shh is missing from 
the oral epithelium (D arrowhead).  (E, G) Ptch1 and Gli1 are expressed in the oral epithelium and 
in the facial mesenchyme (arrowheads).  They show a gradient of transcriptional activity across 
these regions away from the epithelium, the source of hedgehog ligand.  (E-H) In Noggin-/- 
embryos, there is a reduction in the expression of Ptch1 and Gli1 in facial region compared to Wt 
littermates (arrowheads).  (I, J) E12.5 frontal sections.  Ptch1 expression domain smaller in 
Noggin-/- mice compared to Wt littermates (arrowheads).  fe, facial ectoderm; fnp, frontonasal 
process; mp, mandibular process; ne, neural ectoderm; oe, oral epithelium; pe, pharyngeal 
endoderm. Scale bars: A, 200 µm; I 500 µm. (A-H, same magnification) (I and J, same 
magnification).   
 
Figure 4.  BMP4 downregulates Fgf8 and Ptch1 in the developing mouse face.  (A-D) Wt mouse 
heads cultured overnight with beads impregnated with BMP4 or BSA. (A, B) E10.5 whole mount 
in situ hybridization for Fgf8. Fgf8 is downregulated in the nasal pit in response to BMP4.  (C, D) 
E11.5 whole mount in situ hybridization for Ptch1. Ptch1 is downregulated in mesenchyme 
underlying the nasal pit in response to BMP4 (arrow) but Ptch1 expression is maintained in the 
contralateral side (C arrowhead) and in response to BSA (negative control, D arrowheads).  Nasal 
pits demarcated with red dotted lines.  Asterisks indicate bead locations. Scale bars 500 µm. (A 
and B, same magnification) (C and D, same magnification).   
 
Figure 5. Palate and hyoid bone development in Noggin-/- mice. (A-H) Hematoxylin and eosin 
stained frontal sections of Wt heads and Noggin-/- heads E12.5-E16.5.  In Wt mice the palatal shelf 
primordia bud from the maxillary processes (A), they extend into a position between the tongue 
and the floor of the mouth (C) then elevate to a position between the tongue dorsum and the nasal 
capsule (E) and fuse in the midline. (D) In contrast, the palatal shelves of Noggin-/-  mice were in a 
position above the tongue, already at E13.5.  (D and F) Also, the shape of the Noggin-/-  palatal 
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shelves was not ‘finger-like’ but more bulbous.  (H) At E16.5 the palatal shelves of Noggin-/-  mice 
appeared normal having fused together.   
(I-L) Alcian blue and alizarin red staining of hyoid bones from Wt and Noggin-/- mice.  (I, 
J) At E16.5 the Noggin-/- hyoid is bigger than its Wt counterpart. In both Wt and Noggin-/- mice the 
body of the hyoid has started to mineralize (arrowheads).  (K, L) At E18.5 the body of the Noggin-
/- hyoid bone is larger.  It has four instead of two cornua which are thicker, shorter and prematurely 
mineralized compared to their Wt littermates.  b, body of the hyoid bone; gc, greater cornua of 
hyoid bone; m, upper molar tooth; mc, Meckel’s cartilage; nc, nasal cavity; np, nasal projection of 
the maxillary bone; ns; cartilage primordium of the nasal septum; oc, oral cavity; t, tongue; vc, 
vomeronasal cartilage; * palatal shelves.  Scale bars: A 500 µm, I 1 mm. (A-H, same 
magnification) (I-L, same magnification).   
 
Figure 6.  Abnormalities of the vomeronasal organ in Noggin-/- mice.  (A-F) E16.5 Hematoxylin 
and eosin stained frontal sections of Wt and Noggin-/- heads showing the developing nasal septum 
and vomeronasal organ.  The vomeronasal organ is similar in Wt and Noggin-/- mice (arrowheads), 
however the vomeronasal cartilage (vc) which cups the Wt vomeronasal organ is missing in 
Noggin-/- mice, the mesenchyme surrounding the vomeronasal organ is reduced as is the 
developing nasal projection of the maxillary bone.  The cartilage of the nasal septum is greatly 
enlarged in Noggin-/- mice.  np, nasal projection of the maxillary bone; ns; cartilage primordium of 
the nasal septum; vc, vomeronasal cartilage.  Scale bar: A 200 µm, (A-F, same magnification).   
 
Supplemental Figure 1.  Expression of Bmp2, -4 and -7 in the developing mouse craniofacial 
region.  35S-in situ hybridization of Wt midline sagittal sections.  (A-K) E10.5, Bmp2 is expressed 
in the nasal epithelium but not in the oral or facial epithelia or facial mesenchyme.  Bmp4 and 
Bmp7 are expressed in the facial, oral and mandibular epithelia, and in the mesenchyme of the 
frontonasal mass and the mandible.  Bmp2, Bmp4 and Bmp7 are all expressed in the epithelium of 
the telencephalon and diencephalon.  (L-N) E12.5, Bmp2 is expressed in the oral epithelium, 
pharyngeal endoderm, tongue and mandibular process. Bmp4 is expressed in the mesenchyme of 
the frontonasal process, in the tongue epithelium as well as in the mandibular process.  Bmp7 is 
expressed in the facial and oral epithelia and in the facial mesenchyme.  di, diencephalon; fe, facial 
ectoderm; fnp, frontonasal process; mp, mandibular process; oe, oral epithelium; pe, pharyngeal 
endoderm; te, telencephalon. Scale bar: 200 µm. (A-C, same magnification), (D-K, same 
magnification), (L-N, same magnification).   
 
Supplemental Figure 2.  Pituitary development in Noggin-/- mice.  (A-H) E13.5, hematoxylin and 
eosin stained paracoronal sections to show the developing pituitary gland in Wt (A, C, E, G) and 
Noggin-/- (B, D, F, H) mice.  The most notable feature in Noggin-/- mice is that the developing 
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pituitary is smaller, especially the pars anterior of the adenohypophysis.  ap, pars anterior; i, 
infundibulium; ir, infundibular recess of the 3rd ventricle; lrp, lumen of Rathke’s pouch; s, 
cartilaginous primordium of the sphenoid bone.   
 








